Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Active Comparator in Schizophrenia
NCT00036088Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2001
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 4 trial of olanzapine in schizophrenia, sponsored by Eli Lilly and Company. Started Aug 2001; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00036088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036088.